Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Erreger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Ebiomedicine|March 17, 2015
Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviorsEtienne Cartier, Peter J Hamilton, Andrea N Belovich, et al.
Molecular Pharmacology|July 12, 2007
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptorsKevin Erreger, Matthew T Geballe, Anders Kristensen, et al.
Brain : a Journal of Neurology|March 12, 2014
Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthoodJoanne Ng, Juan Zhen, Esther Meyer, et al.
ACS Pharmacology & Translational Science|April 18, 2024
Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual ScreeningShannon T Smith, Jackson B Cassada, Lukas Von Bredow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2019
Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in <i>SLC6A3</i>Nicholas G Campbell, Aparna Shekar, Jenny I Aguilar, et al.
JCI Insight|August 10, 2021
Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric diseaseFreja Herborg, Kathrine L Jensen, Sasha Tolstoy, et al.
The Journal of Clinical Investigation|June 10, 2014
Missense dopamine transporter mutations associate with adult parkinsonism and ADHDFreja H Hansen, Tina Skjørringe, Saiqa Yasmeen, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Ebiomedicine|March 17, 2015
Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviorsEtienne Cartier, Peter J Hamilton, Andrea N Belovich, et al.
Molecular Pharmacology|July 12, 2007
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptorsKevin Erreger, Matthew T Geballe, Anders Kristensen, et al.
Brain : a Journal of Neurology|March 12, 2014
Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthoodJoanne Ng, Juan Zhen, Esther Meyer, et al.
ACS Pharmacology & Translational Science|April 18, 2024
Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual ScreeningShannon T Smith, Jackson B Cassada, Lukas Von Bredow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2019
Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in <i>SLC6A3</i>Nicholas G Campbell, Aparna Shekar, Jenny I Aguilar, et al.
JCI Insight|August 10, 2021
Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric diseaseFreja Herborg, Kathrine L Jensen, Sasha Tolstoy, et al.
The Journal of Clinical Investigation|June 10, 2014
Missense dopamine transporter mutations associate with adult parkinsonism and ADHDFreja H Hansen, Tina Skjørringe, Saiqa Yasmeen, et al.
Pageof 3